Primary versus secondary gliosarcoma: a systematic review and meta-analysis

HG Vuong, IF Dunn - Journal of Neuro-Oncology, 2022 - Springer
Introduction Gliosarcomas are extremely rare malignant brain tumors, which can be
classified as primary gliosarcoma (PGS) if the tumors arise de novo or secondary …

Clinicopathological and Neuroimaging Features of Primary Gliosarcoma: A Case Series and Review of Literature

M Matute-González, A Mosteiro-Cadaval… - World Neurosurgery, 2023 - Elsevier
Background Gliosarcoma (GS) is a rare primary high-grade brain neoplasm with a poor
prognosis and challenging surgical resection. Although it is now considered a morphologic …

Epidemiology of malignant brain tumors in Genova, Italy. 1993–2017

G Frosina, C Casella, A Puppo, E Marani… - Scientific Reports, 2024 - nature.com
We present an updated analysis on the incidence of primary brain tumors in the Metropolitan
Area of Genova, the capital of the northwestern Italian region Liguria. The number of cases …

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment

M Rahban, S Joushi, H Bashiri, L Saso… - Frontiers in …, 2024 - frontiersin.org
Glioblastoma multiforme (GBM) is a highly aggressive malignant primary tumor in the central
nervous system. Despite extensive efforts in radiotherapy, chemotherapy, and neurosurgery …

[HTML][HTML] Differentiating Gliosarcoma from glioblastoma: a novel approach using PEACE and XGBoost to Deal with datasets with ultra-high dimensional confounders

A Saki, U Faghihi, I Baldé - Life, 2024 - mdpi.com
In this study, we used a recently developed causal methodology, called Probabilistic Easy
Variational Causal Effect (PEACE), to distinguish gliosarcoma (GSM) from glioblastoma …

Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma

L Chen, E Rizk, M Sherief, M Chang, CH Lucas… - Journal of neuro …, 2025 - Springer
Purpose Gliosarcoma is a rare histopathological variant of glioblastoma, but it is unclear
whether distinct clinical or molecular features distinguish it from other glioblastomas. The …

Gliosarcoma: A Multi‐Institutional Analysis on Clinical Outcomes and Prognostic Factors

S Roohani, M Mirwald, F Ehret, C Fink… - Cancer …, 2024 - Wiley Online Library
Purpose This study describes oncological outcomes and investigates prognostic factors for
patients with gliosarcomas (GSM). Methods Histopathologically confirmed GSM patients …

Effectiveness and safety of tumor-treating fields therapy for glioblastoma: A single-center study in a Chinese cohort

L She, X Gong, L Su, C Liu - Frontiers in Neurology, 2023 - frontiersin.org
Objective Tumor-treating fields (TTFields) are a new therapeutic modality for patients with
glioblastoma (GBM). However, studies on survival outcomes of TTFields are rarely reported …

Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics

D La Torre, A Della Torre, E Lo Turco, P Longo… - Journal of Clinical …, 2023 - mdpi.com
Gliosarcomas (GS) are sporadic malignant tumors classified as a Glioblastoma (GBM)
variant with IDH-wild type phenotype. It appears as a well-circumscribed lesion with a …

Telomeres and telomerase in Sarcoma disease and therapy

J Huang, Y Feng, YJ Shi, W Shao, G Li… - … Journal of Medical …, 2024 - pmc.ncbi.nlm.nih.gov
Sarcoma is a rare tumor derived from the mesenchymal tissue and mainly found in children
and adolescents. The outcome for patients with sarcoma is relatively poor compared with …